Ultralong Peripheral Nerve Block by Lidocaine:Prilocaine 1:1 Mixture in a Lipid Depot Formulation: Comparison of In Vitro, In Vivo, and Effect Kinetics.

Lars Söderberg; Henrik Dyhre; Bodil Roth; Sven Bjorkman

Ultralong Peripheral Nerve Block by Lidocaine:Prilocaine 1:1 Mixture in a Lipid Depot Formulation: Comparison of In Vitro, In Vivo, and Effect Kinetics.

Lars Söderberg, Henrik Dyhre, Bodil Roth, Sven Bjorkman

Department of Clinical Sciences, Malmö

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	110-121
Journal	Anesthesiology
Volume	104
Issue number	1
Publication status	Published - 2006

Subject classification (UKÄ)

Anesthesiology and Intensive Care

Access to Document

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16394697&dopt=Abstract

Cite this

@article{00a0702219134c5c8223aaa7740d4229,

title = "Ultralong Peripheral Nerve Block by Lidocaine:Prilocaine 1:1 Mixture in a Lipid Depot Formulation: Comparison of In Vitro, In Vivo, and Effect Kinetics.",

author = "Lars S{\"o}derberg and Henrik Dyhre and Bodil Roth and Sven Bjorkman",

year = "2006",

language = "English",

volume = "104",

pages = "110--121",

journal = "Anesthesiology",

issn = "1528-1175",

publisher = "Lippincott Williams \& Wilkins",

number = "1",

}

TY - JOUR

T1 - Ultralong Peripheral Nerve Block by Lidocaine:Prilocaine 1:1 Mixture in a Lipid Depot Formulation: Comparison of In Vitro, In Vivo, and Effect Kinetics.

AU - Söderberg, Lars

AU - Dyhre, Henrik

AU - Roth, Bodil

AU - Bjorkman, Sven

PY - 2006

Y1 - 2006

UR - https://www.scopus.com/pages/publications/33644865613

M3 - Article

SN - 1528-1175

VL - 104

SP - 110

EP - 121

JO - Anesthesiology

JF - Anesthesiology

IS - 1

ER -

Ultralong Peripheral Nerve Block by Lidocaine:Prilocaine 1:1 Mixture in a Lipid Depot Formulation: Comparison of In Vitro, In Vivo, and Effect Kinetics.

Subject classification (UKÄ)

Access to Document

Other files and links

In Vitro – In Vivo Correlation of Injectable Lipid Formulations

Cite this